Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2532258 | 0.86 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL14564492 | 0.83 | — | — | |
| SCHEMBL1046372 | 0.77 | TSHR (0.32) | ALDH1A1TSHRTDP1 | |
| SCHEMBL24335084 | 0.75 | — | — | |
| SCHEMBL766523 | 0.74 | — | — | |
| SCHEMBL5832169 | 0.74 | — | — | |
| Alcohol SCHEMBL3258906 | 0.72 | TSHR (0.47) | ALDH1A1TSHRTDP1 | |
| SCHEMBL1041575 | 0.72 | — | — | |
| SCHEMBL7356273 | 0.72 | — | — | |
| SCHEMBL977704 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066547-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL AND TRANSESTERIFICATION CATALYST | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-119161552-A | Composition, coating composition, aqueous polyurethane dispersion, polyurethane resin and polyurea resin | 旭化成株式会社 | 2024-12-20 | — | — | CN | disclosed |
| EP-4467591-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL, AND TRANSESTERIFICATION CATALYST | Asahi Kasei Kabushiki Kaisha (JP) | 2024-11-27 | — | — | EP | disclosed |
| CN-118660923-A | Method for producing polycarbonate diol, and transesterification catalyst | 旭化成株式会社 | 2024-09-17 | — | — | CN | disclosed |
| EP-2514779-B1 | POLYCARBONATE DIOL-CONTAINING COMPOSITION, PROCESS FOR PRODUCING THE SAME, POLYURETHANE OBTAINED USING THE SAME, AND PROCESS FOR PRODUCING THE POLYURETHANE | MITSUBISHI CHEM CORP (JP) | 2024-04-03 | — | — | EP | disclosed |
| CN-117164839-A | Transesterification catalyst, method for producing polycarbonate diol, and polycarbonate diol | 旭化成株式会社 | 2023-12-05 | — | — | CN | disclosed |
| CN-114364542-B | Method for producing printed matter | 东丽株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-116670108-A | Ether compounds as volatiles for treating amino acid based substrates such as skin and hair | 迈图高新材料有限责任公司 | 2023-08-29 | — | — | CN | disclosed |
| WO-2023140247-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL, AND TRANSESTERIFICATION CATALYST | 旭化成株式会社 | 2023-07-27 | — | — | WO | disclosed |
| US-20220281217-A1 | METHOD FOR MANUFACTURING PRINTED MATTER | TORAY INDUSTRIES, INC. (JP) | 2022-09-08 | — | — | US | disclosed |
| US-5017580-A | Memory enhancing-R-N-(1-azabicyclo[2.2.2.]oct-3-yl)benzamides and thiobenzamides | A.H. ROBINS COMPANY, INCORPORATED A VA CORPORATION | 1991-05-21 | — | — | US | disclosed |
| US-4908370-A | Antianxiety agents | A. H. ROBBINS COMPANY, INC. (US) | 1990-03-13 | — | — | US | disclosed |
| US-4556667-A | (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONE INTERMEDIATES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1985-12-03 | — | — | US | disclosed |
| US-4507294-A | TREATMENT OF PEPTIC ULCERS | SCHERING CORP. (US) | 1985-03-26 | — | — | US | disclosed |
| US-4495183-A | ANTIULCER AGENTS- GASTROLINTESTINAL DISORDERS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1985-01-22 | — | — | US | disclosed |
| US-4447361-A | ANTIDEPRESSANT | A. H. ROBINS COMPANY, INC. (US) | 1984-05-08 | — | — | US | disclosed |
| EP-0068378-A1 | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1983-01-05 | — | — | EP | disclosed |
| US-4139620-A | HYPOTENSIVE AGENTS | A. H. ROBINS COMPANY, INC. (US) | 1979-02-13 | — | — | US | disclosed |
| US-4096331-A | HYPOTENSIVE | A. H. ROBINS COMPANY, INCORPORATED (US) | 1978-06-20 | — | — | US | disclosed |
| US-4021552-A | TRANQUILIZERS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066547-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL AND TRANSESTERIFICATION CATALYST | CYP24A1, CCNE2, DHCR24 | ALDH1A1 1118/4885TSHR 2686/4885TDP1 2947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.